Lyon, 19–20 May 2016 Auditorium

Governing Council
Fifty-eighth Session
GC/58/20
13/05/2016
Lyon, 19–20 May 2016
Auditorium
APPOINTMENT OF NEW MEMBERS OF THE SCIENTIFIC COUNCIL
1.
In accordance with Article VI of the Statute and Resolution GC/54/R16, the term of office
of five members of the Scientific Council, namely Drs Nuria Aragonés (Spain), James Bishop
(Australia), Nicholas Jones (UK), Christos Sotiriou (Belgium) and Teruhiko Yoshida (Japan) will
be completed with the 2016 meeting of the Governing Council.
2.
For the information of the Council, this leaves the following 20 members (seven women
and 13 men) still serving on the Scientific Council: Drs Al-Hareth M. Al-Khater (Qatar), Françoise
Clavel-Chapelon (France), Lukas A. Huber (Austria), Luis Felipe Ribeiro Pinto (Brazil) and John J.
Spinelli (Canada) until 2017; Drs Stephen J. Chanock (USA), Ellen Kampman (The Netherlands),
Ole Raaschou-Nielsen (Denmark), Martin Röösli (Switzerland) and Elisabete Weiderpass-Vainio
(Finland) until 2018; and Drs Boris Alekseev (Russian Federation), Jonas Bergh (Sweden), Jenny
Chang-Claude (Germany), Jerome Coffey (Ireland), Eugenia Dogliotti (Italy), Karima El Rhazi
(Morocco), Kadir Mutlu Hayran (Turkey), Lalit Kumar (India), Dukhyoung Lee (Republic of
Korea) and Giske Ursin (Norway) until 2019.
3.
In accordance with Article VI.2 of the Agency’s Statute, the Governing Council is requested
to select new members to be appointed to the Scientific Council from the attached list of
experts, one each from Australia, Belgium, Japan, Spain and the UK.
Curricula vitae are attached*.
__________
*The curricula vitae will be distributed to Governing Council members only.
GC//58/20
Page 2
Governing Council
Appointment of new members of the Scientific Council
AUSTRALIA
BELGIUM
Professor Adèle Green
University of Queensland
Dr Roberto Salgado
Department of Pathology
GZA Hospital, Antwerp
Field: Cancer etiology, prevention and
implementation research, health services
and policy.
Field: Molecular pathology, breast cancer,
circulating tumour biomarkers.
Professor Mark Jenkins
Director, Centre for Epidemiology and
Biostatistics
University of Melbourne
Field: Genetic epidemiology, identification of
environmental and genetic risk factors, risk
prediction, screening strategies and policies.
JAPAN
SPAIN
Professor Atsushi Ochiai
Exploratory Oncology Research and Clinical
Trial Center
National Cancer Center, Tokyo
Dr Pilar Sánchez Gómez
Neurooncology Unit, Chronic Disease Program
National Health Research Institute Carlos III
Madrid
Field: Mechanisms of cancer progression,
tumour microenvironment, cancer
Field: Brain tumours, preclinical tests,
cancer therapeutics, molecular
pathology, tumour microenvironment.
therapeutics.
Dr Tohru Kiyono
Division of Carcinogenesis and Cancer
Prevention
National Cancer Center Research Institute
Tokyo
Field: Molecular biology, molecular
mechanisms of carcinogenesis, virology.
UK
Professor Dame Valerie Beral
Director, Cancer Epidemiology Unit
Richard Doll Building, University of Oxford
Field: Cancer epidemiology, women’s health.
Professor Simon Tavaré
CRUK Cambridge Institute
University of Cambridge, Li Ka Shing Centre
Field: Cancer genomics, evolutionary
approaches to cancer, statistical
bioinformatics for arrays and sequencing,
computational biology, population genetics.